Trademarkia Logo

Canada

C$
Trademark Search in Canada
NEOZUME

View On IC.GC.CA

NEOZUME
CANCELLED

Last Applicant/ Owned by

BioSplice Therapeutics, Inc.

9360 Towne Centre DriveSan Diego CA 92121

US

Serial Number

2062161 filed on 6th Oct 2020

Registration Number

TMA1166814 registered on 22nd Feb 2023

Registration expiry Date

13th Apr 2030

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

NEOZUME

Trademark usage description

pharmaceutical preparations for treatment of degenerative diseases and conditions, namely, pharmaceuticals for the treatment of diseases of cartilage Read More

Classification Information

Class [005]
Pharmaceutical preparations for treatment of degenerative diseases and conditions, namely, pharmaceuticals for the treatment of diseases of cartilage degeneration, joint and musculoskeletal disorders

Classification kind code

11

Class [042]
Research and development in the pharmaceutical and biotechnology fields

Classification kind code

11

Mark Details

Serial Number

2062161

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 2th Mar 2022		Search Recorded
Submitted for opposition 20
on 2th Mar 2022		Examiner's First Report
Submitted for opposition 223
on 2th Mar 2022		Total Provisional Refusal
Submitted for opposition 256
on 6th Sept 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 21st Apr 2021		Agent Changed
Submitted for opposition 257
on 5th Nov 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 4th Nov 2020		Created
Submitted for opposition 31
on 4th Nov 2020		Formalized
Submitted for opposition 30
on 6th Oct 2020		Filed
Submitted for opposition 228
on 13th Apr 2020		International Registration